Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

Agree with your sentiment, while its nice to think simple switch of the flick could run us back to $20, the reality is that the current erosion in value reflects the challenges the company faces as a result of poor business decisions and misguided excessive spending by O'Connor. If the HOT IND is filed with a money paying BP deal things could change. Otherwise the current value is an accurate reflection of the financial mismament of the company over the last five years. O'Connor was appropriately replaced, but the question remains why have there been no changes at the Board level given their missteps from a governance perspective. O'Connor was the mastermind in the value destruction, but Sid (The Rat) Ransky stood by and did nothing to stop it early on.